Review
Nature Reviews Molecular Cell Biology 9, 193-205 (March 2008) | doi:10.1038/nrm2327
Article series: Mechanisms of disease
Molecular and metabolic mechanisms of insulin resistance and 
-cell failure in type 2 diabetes
Deborah M. Muoio1 & Christopher B. Newgard1 About the authors
Abstract
Nearly unlimited supplies of energy-dense foods and technologies that encourage sedentary behaviour have introduced a new threat to the survival of our species: obesity and its co-morbidities. Foremost among the co-morbidities is type 2 diabetes, which is projected to afflict 300 million people worldwide by 2020. Compliance with lifestyle modifications such as reduced caloric intake and increased physical activity has proved to be difficult for the general population, meaning that pharmacological intervention may be the only recourse for some. This epidemiological reality heightens the urgency for gaining a deeper understanding of the processes that cause metabolic failure of key tissues and organ systems in type 2 diabetes, as reviewed here.
- View At a Glance
Author affiliations
- Sarah W. Stedman Nutrition and Metabolism Center, Department of Pharmacology and Cancer Biology and Department of Medicine, Duke University Medical Center, 4321 Medical Park Drive, Durham, North Carolina 27704, USA.
Correspondence to: Christopher B. Newgard1 Email: newga002@mc.duke.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistanceNature Medicine Article (01 Mar 2004)
Metabolic Syndrome: Adenosine Monophosphate-activated Protein Kinase and Malonyl Coenzyme AObesity Article Response
See all 5 matches for Research
